Anthem Biosciences Limited (NSE:ANTHEM)

Revenue by Segment

Financials in millions INR. Fiscal year is April - March.

Year Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Development & Manufacturing	8.98B
Development & Manufacturing Growth	41.36%
Speciality Ingredients	3.36B
Speciality Ingredients Growth	35.11%
Research & Development Services	1.86B
Research & Development Services Growth	7.18%

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Year Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Europe	6.13B
Europe Growth	100.13%
North America (USA)	4.29B
North America (USA) Growth	-14.17%
India	3.09B
India Growth	45.12%
Rest of Asia & Others	681.44M
Rest of Asia & Others Growth	81.74%